Just spoke to the company and I'm more than happy with how things are progressing.
The company is not able to release an ASX announcement as no new information is available. In fact the ASX has previously denied announcements on that basis. In effect, the following is re-iterated: - no news is good news - all options are on the table with multiple parties - prospective partners know that VitroGro is the biggest improvement in wound therapy for 50 years - some also feel threatened as it could hurt their revenue for existing products
There's also added complexity as there could be more than 1 deal for different market segments.
Basically, it seems the ball is in TIS's court, but they're not rushing things to meet short-term targets.
I encourage you to ring the company if you're concerned about missing this "target" date, but I have confidence in management to do the right thing and get a deal done in the near term. They hold all the aces.
TIS Price at posting:
65.6¢ Sentiment: Hold Disclosure: Held
